Yanxia Chen

Dr. Yanxia Chen


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2022 in Hematology
Verified
Journal Article
Open access
CYChunmei Ye
Chunmei Ye
YXYuni Xu
Yuni Xu
ZWZhenni Wang
Zhenni Wang
YCYanxia Chen
Yanxia Chen
JLJinlin Liu
Jinlin Liu
Objective Follicular helper T cells (Tfh) drive proliferation and differentiation of B cells into plasma cells, leading to antibody production; however, their role in multiple myeloma (MM) is unknown. We aimed to determine the alteration of Tfh subsets and their clinical significance in patients with MM. Method Forty-nine patients with MM were recruited in this study, including 12 newly diagnosed patients, 10 relapsed patients, and 8 patients who received autologous hematopoietic stem cell transplantation (ASCT) from Zhejiang Provincial People's Hospital. Total CD4 + CXCR5 + CD25lowCD127intermediate-high Tfh cells, CXCR3 + CCR6−Tfh1 cells, CXCR3−CCR6−Tfh2 cells, and CXCR3−CCR6 + Tfh17 cells from the peripheral blood of these patients were analyzed by flow cytometry. Result Although total Tfh cells were not significantly changed in patients with MM compared to that in healthy controls (HCs), the Tfh17/Tfh ratio was significantly elevated in patients with MM compared to that in HCs (P = 0.0001). Importantly, relapsed patients had higher Tfh17/Tfh ratio than the newly diagnosed patients (P = 0.0077). Moreover, the Tfh17/Tfh ratio was significantly decreased in patients with MM who received ASCT (post-ASCT) when compared to that in HCs and non-ASCT patients (P < 0.0001), but no change was observed between post-ASCT patients and HCs (P = 0.7498). Conclusion The Tfh17/Tfh ratio was significantly elevated in patients with MM, especially in relapsed patients, indicating that Tfh17 cells may play a critical role in the clinical progression of MM.

6 July 2023 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
XCXiaojuan Chen
Xiaojuan Chen
JZJiwei Zhao
Jiwei Zhao
LCLin Chen
Lin Chen
YCYanxia Chen
Yanxia Chen
JLJinlin Liu
Jinlin Liu

10 March 2020 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
JNJinyao Ni
Jinyao Ni
JZJunwu Zhang
Junwu Zhang
QCQi Chen
Qi Chen
YCYanxia Chen
Yanxia Chen
JLJinlin Liu
Jinlin Liu
Background: Selective immunoglobulin M deficiency (SIgMD) is a rare primary immunodeficiency that is frequently reported in Western countries. However, large epidemiological and clinical studies of SIgMD in China are still lacking. Herein, we describe a cohort of SIgMD subjects in a large tertiary university hospital in China.Methods: A cross‐sectional study included 139 668 participants at First Affiliated Hospital of Wenzhou Medical University from January 2014 to October 2018 was conducted. Individuals with a serum IgM level less than 0.3 g/L with normal levels of serum IgA and IgG were defined as having SIgMD.Result: A total of 63 subjects met the criteria for SIgMD(63/139668, 0.045%), with a male‐to‐female ratio of 0.85, aged from 19 to 99 years. The most common clinical manifestation was autoimmune disorders (38/63, 60.32%), while the second most common manifestation was infections (21/63, 33.33%). Neither allergies nor tumors were found among these 63 SIgMD subjects. Most importantly, there were 30 patients with systemic lupus erythematosus among these 63 SIgMD subjects, accounting for 47.62% of all SIgMD subjects.Conclusion: To our knowledge, we describe here the first large single‐center cohort of adult patients affected by SIgMD in China. The most common clinical manifestation was autoimmune disorders, specifically systemic lupus erythematosus.

14 June 2024 in Medicine
Verified
Journal Article
Open access
JZJunwu Zhang
Junwu Zhang
JNJinyao Ni
Jinyao Ni
WKWanzhong Kong
Wanzhong Kong
JLJinlin Liu
Jinlin Liu
YCYanxia Chen
Yanxia Chen
High Immunoglobulin E(IgE) levels associated with hypersensitivity or parasitic infection were well established, but the clinical significance of ultra-low IgE was largely unknown. Previous studies indicated these patients have an elevated risk of cancer, but large-scale epidemiological studies on the prevalence and clinical manifestations of these ultra-low IgE patients are still lacking. A total of 62,997 patients who were admitted to the First Affiliated Hospital of Wenzhou Medical University and had IgE level tests from January 2010 to March 2020 were included. Patients with serum IgE levels < 2 IU/mL were defined to have ultra-low IgE. And the clinical characteristics of these patients were retrospectively analyzed based on electronic medical record system and follow-up. A total of 223 patients (223/62,997, 0.35%) had ultra-low IgE were documented in 62,997 patients who had IgE tests. Among the clinical manifestations of these 223 ultra-low IgE patients, infection ranked first (125/223, 56.05%), following allergic diseases (51/223, 22.87%), hematological disorders (37/223, 16.59%), tumor (27/223, 12.11%) and autoimmune diseases (23/223, 10.31%). To the best of our knowledge, we first reported that the prevalence and clinical characteristics of 223 ultra-low IgE patients in China. The most common comorbidities were infection, allergic diseases, hematological disorders, tumor and autoimmune diseases.

26 July 2020 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
JZJunwu Zhang
Junwu Zhang
WKWanzhong Kong
Wanzhong Kong
JNJinyao Ni
Jinyao Ni
ZGZhen Guo
Zhen Guo
XYXunjun Yang
Xunjun Yang
JLJinlin Liu
Jinlin Liu
Background: Selective immunoglobulin A deficiency (SIgAD) is the most common primary antibody deficiency disease and frequently reported in the Western countries. However, large‐scale epidemiologic studies on SIgAD in China are still lacking.Methods: The clinical information of 555 180 subjects (age >4 years) including the outpatient, inpatient, and healthy subjects who had ordered serum immunoglobulin A, G, M in 9 hospitals of Zhejiang Province in China was collected. The SIgAD individuals were defined as IgA level age >4 years). For adults, the common clinical features were infections (43/87, 49.43%), autoimmune disorders (31/87, 35.63%), allergic cases (5/87, 5.75%), and tumor cases (4/87, 4.60%). Additionally, infectious diseases (20/22, 90.91%), autoimmune disorders (4/22, 18.18%), and allergic cases (1/22, 4.55%) were found in 22 children.Conclusion: We first describe a large cohort of SIgAD individuals of Zhejiang Province in China. The incidence was 0.020%. The common clinical features were infection, autoimmune disorders, tumor, and allergy, and the infection rate was higher in children than the adults.

21 June 2023 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
FYFang Yang
Fang Yang
JZJiwei Zhao
Jiwei Zhao
JWJieying Wang
Jieying Wang
JLJiangrong Liao
Jiangrong Liao
JLJinlin Liu
Jinlin Liu
YCYanxia Chen
Yanxia Chen